Brochure
29 Oct 2016

Company Profile and Product Portfolio

PDF 35 kB
Content provided by our supplier

Murli Krishna Pharma Pvt Ltd

  • IN
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator

Other Content from Murli Krishna Pharma Pvt Ltd (2)

  • News Murli Krishna Pharma Pvt at CPHI North America

    We are pleased announce we are participating in CPHI North America 2019.
  • Video Nab Paclitaxel (Albumin Bound)

    Murli Krishna Pharma is one of the few companies from India who have developed Albumin bound Paclitaxel. The particle size and the encapsulation efficiency have matched with the innovator’s specifications. In Vitro Cell line studies have shown that the activity is comparable to the innovator.